Rachel Lenington, COO AND CDO at Athira Pharma, Inc. (ATHA), sold 2,412 shares at $2.91 ($7K) on 2024-01-05, disclosed to the SEC on 2024-02-16.
Open-market sale of $7k ATHA by COO AND CDO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |